What is the history of Congenital bilateral perisylvian syndrome?

TL;DR: Congenital bilateral perisylvian syndrome (CBPS) was first formally characterized in the early 1990s as a distinct neurological disorder defined by polymicrogyria in the perisylvian regions. Historically understood through clinical observation, our knowledge of Congenital bilateral perisylvian syndrome has evolved significantly due to advanced neuroimaging and the identification of specific genetic mutations associated with cortical development.

When was Congenital bilateral perisylvian syndrome first described?

While clinicians had observed children with similar clusters of symptoms—specifically pseudobulbar palsy, oropharyngeal dysphasia, and epilepsy—for decades, the condition was not formally defined as a distinct clinical entity until 1993. In that year, researchers led by Dr. Kuzniecky provided the definitive characterization of Congenital bilateral perisylvian syndrome. By utilizing high-resolution magnetic resonance imaging (MRI), they identified the hallmark feature: bilateral perisylvian polymicrogyria, a malformation where the surface of the brain has an excessive number of abnormally small folds.

How has our understanding of Congenital bilateral perisylvian syndrome evolved?

In the early years following its discovery, Congenital bilateral perisylvian syndrome was often misdiagnosed as cerebral palsy or primary speech-language disorders because of the prominent oromotor deficits. As neuroimaging technology became more accessible in the late 1990s and early 2000s, clinicians began to recognize that the speech and swallowing difficulties were not functional but structural in origin. Modern research has shifted the focus from purely clinical observation to genetic investigation, revealing that the condition is rarely a simple "syndrome" but rather a spectrum of cortical malformations with diverse etiologies.

What historical misconceptions surrounded this condition?

Historically, the cognitive and motor impairments observed in patients with Congenital bilateral perisylvian syndrome were sometimes misattributed to early childhood trauma or lack of stimulation. Before the widespread use of MRI, the structural malformations in the perisylvian cortex remained invisible, leading to "diagnostic odysseys" where families were told their children had generalized intellectual disabilities without a clear anatomical cause. The transition from behavioral-based diagnosis to imaging-based diagnosis was a major milestone that provided validation for many families who knew their children’s challenges were neurological rather than developmental.

How has modern technology changed the landscape for patients?

The integration of advanced genetics and neuroimaging has fundamentally changed how we manage Congenital bilateral perisylvian syndrome. Today, we know that mutations in genes like SRPX2, COL4A1, and TUBB2B are implicated in various forms of perisylvian polymicrogyria. This shift has allowed for:

• Precise molecular diagnosis through whole-exome sequencing.


• Improved management of refractory epilepsy, which affects a large percentage of those with Congenital bilateral perisylvian syndrome.


• Earlier intervention for speech and feeding therapies, which are critical for quality of life.


• Better genetic counseling for families regarding the recurrence risks associated with specific genetic variants.

The growth of patient advocacy

The history of Congenital bilateral perisylvian syndrome is also a story of community. With 45 members currently connected through DiseaseMaps.org, patients and caregivers have moved from isolation to a global network of shared knowledge. Advocacy groups have played a vital role in pushing for more research into the long-term prognosis of the condition, ensuring that the clinical focus extends beyond childhood milestones into the challenges of adulthood.

Next steps

• Consult with a board-certified pediatric neurologist or geneticist to review the latest imaging and genetic testing options.


• Connect with the community on DiseaseMaps.org to share experiences and coping strategies with others navigating the same journey.


• Work with a multidisciplinary team, including speech-language pathologists and physical therapists, to tailor a supportive care plan.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Kuzniecky R, et al. (1993). "Bilateral perisylvian polymicrogyria: a distinct clinical and neuroimaging syndrome." Neurology.


• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD).


• Online Mendelian Inheritance in Man (OMIM) - Entry regarding perisylvian polymicrogyria.


• Orphanet: The portal for rare diseases and orphan drugs.